| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Cadmium |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01503
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cadmium inhibits the expression of DME DTYMK |
[1] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Polychlorinated biphenyls |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00776
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Carcinogen |
| DME Modulation |
Polychlorinated biphenyls induces the drug-metabolizing activity of DME DTYMK |
[2] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Tris(1,3-dichloro-2-propyl)phosphate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01031
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME DTYMK |
[3] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Geraniol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01312
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Geraniol inhibits the expression of DME DTYMK |
[4] |
| Traditional Medicine |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Jinfukang |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00760
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Traditional Medicine |
| DME Modulation |
Jinfukang up-regulates the expression of DME DTYMK |
[5] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 11 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen up-regulates the expression of DME DTYMK |
[6] |
| Calcitriol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Calcitriol inhibits the expression of DME DTYMK |
[7] |
| Cisplatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin up-regulates the expression of DME DTYMK |
[8] |
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME DTYMK |
[9] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME DTYMK |
[10], [11] |
| Estradiol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Estradiol up-regulates the expression of DME DTYMK |
[12] |
| Fluorouracil |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00037
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Fluorouracil up-regulates the expression of DME DTYMK |
[13] |
| Leflunomide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00053
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Leflunomide inhibits the expression of DME DTYMK |
[14] |
| Nicotine polacrilex |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00312
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Nicotine polacrilex inhibits the expression of DME DTYMK |
[15] |
| Troglitazone |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00086
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Troglitazone inhibits the expression of DME DTYMK |
[16] |
| Valproic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Valproic acid inhibits the expression of DME DTYMK |
[17] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Epigallocatechin gallate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00613
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Epigallocatechin gallate inhibits the expression of DME DTYMK |
[18] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Bisphenol A inhibits the expression of DME DTYMK |
[19] |
| Genistein |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00557
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Genistein up-regulates the expression of DME DTYMK |
[12] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| K-7174 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
K-7174 inhibits the expression of DME DTYMK |
[20] |
|
|
|
|
|
|